triiodothyronine and Autoimmune Thyroiditis studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research Excerpts

Excerpt	Relevance	Reference
"The protective effects and potential mechanisms of dioscin for autoimmune thyroiditis were explored in a rat model of thyroglobulin-induced autoimmune thyroiditis."	8.31	Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling. ( Liu, T; Qin, L; Wu, L; Yan, Z; Zhang, C; Zhang, Q, 2023)
"The use of levothyroxine to reduce thyroid size in pediatric patients with goiter due to chronic autoimmune thyroiditis (AIT) remains controversial."	7.73	Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. ( Ericsson, UB; Ivarsson, SA; Jonsson, B; Lindberg, B; Nilsson, P; Olsson, C; Svensson, J, 2006)
"The neonates from mothers with AITD, independently of the presence also of TRab in the mothers, had a transient hyperthyroxinemia one week following birth."	7.73	Transient hyperthyroxinemia in newborns from women with autoimmune thyroid disease and raised levels of thyroid peroxidase antibodies. ( Kvetny, J; Poulsen, H, 2006)
"Hyperhomocysteinemia is a risk factor for premature atherosclerotic vascular disease and venous thrombosis."	7.72	Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism. ( Atabek, ME; Erkul, I; Pirgon, O, 2003)
"To compare the effects of pregnancy on the serum free thyroxine (FT4) levels in two cohorts of primary hypothyroid women treated with different levothyroxine (L-T4) doses before gestation."	7.72	Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. ( Amato, G; Carella, C; Cioffi, M; Mazziotti, G; Piscopo, M; Rotondi, M; Sorvillo, F, 2004)
"Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts."	7.69	Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997)
"Anti-triiodothyronine antibody was found in a case of rheumatoid arthritis associated with Hashimoto's thyroiditis."	7.67	[Anti-triiodothyronine antibodies in patients with rheumatoid arthritis associated with Hashimoto's thyroiditis]. ( Chinen, Y; Imura, H; Ishii, K; Kuno, S; Nagaoka, K; Nakayama, A; Sato, S; Takegami, T; Togashi, K; Ueno, Y, 1985)
"Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma."	7.67	Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986)
"A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients."	7.66	Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978)
"Sodium-L-thyroxine (T4) was utilized in the treatment of 15 pediatric patients with hypothyroidism."	7.65	Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. ( Abbassi, V; Aldige, C, 1977)
"Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment."	5.56	Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis. ( Han, X; Ji, L; Li, M; Liu, W; Ren, Q; Wang, C; Wu, Z; Yang, W; Zhang, M; Zhang, S; Zhou, L; Zhu, Y, 2020)
"Autoimmune gastritis is an additional factor affecting l-T(4) requirement in patients with autoimmune thyroiditis."	5.35	L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. ( Checchi, S; Chiappetta, MC; Ciuoli, C; De Palo, V; Montanaro, A; Pacini, F; Pasqui, L, 2008)
"Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI."	5.29	Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994)
"Fifteen patients who had hypothyroidism caused by CAT and were undergoing levothyroxine (LT4) treatment were selected to participate in the study."	5.14	Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. ( Cerri, GG; Chammas, MC; Chavantes, MC; Höfling, DB; Juliano, AG; Romão, R; Yoshimura, EM, 2010)
"Selenium completed with L-thyroxine is a suitable therapy for patients with autoimmune thyroiditis."	5.13	[The effect of selenium therapy on autoimmune thyroiditis]. ( Balázs, C, 2008)
"To test whether thyroid hormone regulates MBL levels, we studied eight patients with Graves' hyperthyroidism before and after methimazole therapy, eight healthy subjects before and after short-term experimental hyperthyroidism, and eight hypothyroid patients with chronic auto-immune thyroiditis before and after L-thyroxine substitution."	5.11	Thyroid hormone increases mannan-binding lectin levels. ( Gjedde, S; Gormsen, LC; Gravholt, CH; Hansen, TK; Jørgensen, JO; Møller, N; Riis, AL; Thiel, S; Weeke, J, 2005)
" During pregnancy, mildly elevated maternal free thyroxine levels less than 20% above the upper limit may not be harmful to unaffected fetuses."	4.98	Resistance to thyroid hormone β in autoimmune thyroid disease: a case report and review of literature. ( Guan, H; Guo, H; Guo, R; Li, Y; Shan, Z; Wu, D, 2018)
"The protective effects and potential mechanisms of dioscin for autoimmune thyroiditis were explored in a rat model of thyroglobulin-induced autoimmune thyroiditis."	4.31	Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling. ( Liu, T; Qin, L; Wu, L; Yan, Z; Zhang, C; Zhang, Q, 2023)
" Autoimmune hypothyroidism is frequently associated with obesity, it is usually progressive and needs replacement treatment with L-thyroxine."	4.12	Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity. ( Basolo, A; Bechi Genzano, S; Ceccarini, G; Chiovato, L; Fierabracci, P; Rotondi, M; Salvetti, G; Santini, F; Scartabelli, G; Sotgia, G, 2022)
" A diagnosis of autoimmune thyroiditis (AT) in thyrotoxic phase was made on the basis of clinical presentation and presence of anti-TPO antibodies and reduced uptake in thyroid (technetium) scintigraphy."	3.91	Auto-immune Thyroiditis in an Infant Masquerading as Congenital Nephrotic Syndrome. ( Bavdekar, SB; Jondhale, SN; Koppikar, RG; Save, SU, 2019)
" Thyroid-stimulating hormone, free triiodthyronine, free thyroxine, thyroid peroxidase antibodies, thyroglobulin antibodies were measured and ultrasound evaluation of the thyroid gland was performed in the first trimester of pregnancy and during the first year following delivery."	3.83	Postpartum thyroid dysfunction in women with autoimmune thyroiditis. ( Argatska, A; Nonchev, B; Orbetzova, M; Pehlivanov, B, 2016)
" Serum free triiodothyronine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH), anti-thyroperoxidase antibody (anti-TPO Ab) and anti-thyroglobulin antibody (anti-Tg Ab), lipid profile, hs-CRP, fasting insulin levels were measured and insulin resistance calculated by HOMA-IR."	3.81	The association of autoimmune thyroiditis and non-functional adrenal incidentalomas with insulin resistance. ( Arslan, MS; Calıskan, M; Delibasi, T; Demirci, T; Erden, G; Karakose, M; Karbek, B; Sahin, M; Topaloglu, O, 2015)
"A total of 20 women with subclinical hypothyroidism and 22 patients taking L-thyroxine replacement therapy for hypothyroidism were enrolled in the study."	3.79	Clinical significance of TSH circadian variability in patients with hypothyroidism. ( Fadeyev, VV; Melnichenko, GA; Sviridonova, MA; Sych, YP, 2013)
" L-thyroxine management of hypothyroidism was not associated with significant Ghrelin variations."	3.75	Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction. ( Bartalena, L; Bogazzi, F; Broglio, F; Dalle Mule, I; Gandolfo, M; Genovesi, M; Ghigo, E; Grasso, L; Lai, A; Lombardi, V; Martino, E; Tanda, ML; Ultimieri, F, 2009)
"The use of levothyroxine to reduce thyroid size in pediatric patients with goiter due to chronic autoimmune thyroiditis (AIT) remains controversial."	3.73	Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. ( Ericsson, UB; Ivarsson, SA; Jonsson, B; Lindberg, B; Nilsson, P; Olsson, C; Svensson, J, 2006)
"The neonates from mothers with AITD, independently of the presence also of TRab in the mothers, had a transient hyperthyroxinemia one week following birth."	3.73	Transient hyperthyroxinemia in newborns from women with autoimmune thyroid disease and raised levels of thyroid peroxidase antibodies. ( Kvetny, J; Poulsen, H, 2006)
"Hyperhomocysteinemia is a risk factor for premature atherosclerotic vascular disease and venous thrombosis."	3.72	Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism. ( Atabek, ME; Erkul, I; Pirgon, O, 2003)
"To compare the effects of pregnancy on the serum free thyroxine (FT4) levels in two cohorts of primary hypothyroid women treated with different levothyroxine (L-T4) doses before gestation."	3.72	Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. ( Amato, G; Carella, C; Cioffi, M; Mazziotti, G; Piscopo, M; Rotondi, M; Sorvillo, F, 2004)
"Although the normal thyroid gland secretes both levothyroxine (L-T4) and levotriiodothyronine (L-T3), normalization of serum TSH with L-T4-replacement therapy alone in hypothyroidism is generally believed to result in a normal serum L-T3 and to reflect a euthyroid state."	3.71	Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. ( Woeber, KA, 2002)
" The paralysis was reversed on oral potassium (40 mmol) Thyroid function tests revealed hyperthyroidism with an increased concentration of free thyroxine (25."	3.69	[Periodic paralysis as the first manifestation of hyperthyroidism]. ( Ferbert, A; Fiedler, M; Schulze-Bonhage, A, 1996)
"Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts."	3.69	Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997)
"Serum total and free T4 and T3, thyroxine-binding globulin (TBG) and TSH, basal and 20, 30 and 60 min after TRH (200 micrograms, iv), were evaluated in 125 hypothyroid patients (38 with severe, 23 with mild, and 64 with subclinical hypothyroidism), in 35 euthyroid subjects with autoimmune thyroiditis, and in 51 healthy controls."	3.67	Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis. ( Boghen, M; Codecasa, F; Ferrari, C; Gerevini, G; Mucci, M; Paracchi, A; Parisio, E; Rampini, P, 1987)
"Basal (B) and peak (P) serum levels of thyroxine (T4), free thyroxine (FT4), triiodothyronine (T3), free triiodothyronine (FT3), and TSH were measured before and after oral TRH (40 mg) administration in 79 subjects affected with asymptomatic autoimmune thyroiditis (AAT) and in 69 normal subjects."	3.67	Thyroid hormone reserve in asymptomatic autoimmune thyroiditis. ( Bonnyns, M; Buydens, P; Deboel, S; Finne, E; Jonckheer, M; Smitz, J; Vanhaelst, L, 1987)
"Thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) were detected by the immunoperoxidase method in 51 cases of the following thyroid diseases: euthyroid goiter, Basedow's disease, Hashimoto's thyroiditis, folliculo-papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullary carcinoma."	3.67	Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. ( Stefăneanu, L; Taşcă, C, 1986)
"Anti-triiodothyronine antibody was found in a case of rheumatoid arthritis associated with Hashimoto's thyroiditis."	3.67	[Anti-triiodothyronine antibodies in patients with rheumatoid arthritis associated with Hashimoto's thyroiditis]. ( Chinen, Y; Imura, H; Ishii, K; Kuno, S; Nagaoka, K; Nakayama, A; Sato, S; Takegami, T; Togashi, K; Ueno, Y, 1985)
"The duration of the hyperthyroidism associated with lymphocytic thyroiditis (LT) with spontaneously resolving hyperthyroidism (SRH) was serially monitored in groups of patients who were not given any treatment (control subjects) or treated with propylthiouracil and/or propranolol hydrochloride and prednisone."	3.66	Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). ( Coombs, GJ; McKenzie, AK; Miller, RW; Nikolai, TF; Weir, GJ, 1982)
"A dose (3 g) of sodium ipodate used routinely in oral cholecystography caused a fall in serum 3,5,3'-triiodothyronine and a rise in serum 3,3',5'-triiodothyronine in three patients taking thyroxine (T4), four euthyroid subjects,and four hyperthyroid patients."	3.66	Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. ( Bennett, LR; Chopra, IJ; Solomon, DH; Wu, SY, 1978)
"Patients with breast cancer were studied with regard to changes in the levels of serum thyroxine (T4) and serum triidothyronine (T3) after intramuscular administration of TSH for three days to investigate the thyroid reserve in these patients."	3.65	The thyroid reserve in patients with breast cancer. ( Abe, R; Kimura, M; Saito, S; Sakurada, T; Yoshida, K, 1977)
"A 34-year-old woman with an organic psychosis was presumed to be suffering from corticosteroid psychosis because of prednisone treatment for urticaria."	3.65	Problems in diagnosis and treatment of lupus psychosis. Report of a patient with systemic lupus erythematosus, Hashimoto's thyroiditis, and Sjögren's syndrome. ( Denko, JD, 1977)
"Sodium-L-thyroxine (T4) was utilized in the treatment of 15 pediatric patients with hypothyroidism."	3.65	Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. ( Abbassi, V; Aldige, C, 1977)
"Radioimmunoassay of thyroxine and triiodothyronine in a 14-year-old girl with primary hypothyroidism and nodular goitre as a result of Hashimoto's thyroiditis gave falsely low values due to the presence of hormone-binding antibodies."	3.65	[False radioimmuno-assay of thyroxine and triiodothyronine in the presence of hormone-binding autoantibodies in serum (author's transl)]. ( Herrmann, J; Kley, HK; Kröll, HJ; Krüskemper, HL; Rudorff, KH, 1976)
"Subacute thyroiditis, autoimmune thyroiditis and an atypical form of thyroiditis are complications of COVID-19."	2.72	Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). ( Somogyi, P; Speer, G, 2021)
"Hypothyroidism impacts aspects of cognitive functioning and mood."	2.44	Neuropsychiatric aspects of hypothyroidism and treatment reversibility. . ( Davis, JD; Tremont, G, 2007)
"Hypothyroidism, Chronic autoimmune thyroiditis, Omentin-1."	1.91	Omentin-1 Levels in Hypothyroid Patients with Autoimmune Thyroiditis. ( Cekin, AH; Ellidag, HY; Gorar, S; Kir, S; Sari, IK; Yilmaz, E, 2023)
"The higher prevalence of autoimmune thyroiditis in the PsA group may be due to an immune dysfunction pathway in patients with psoriatic arthritis with a higher risk to develop other autoimmune diseases."	1.62	Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? ( Balato, A; Costa, L; Fabbrocini, G; Gallo, L; Lupoli, GA; Megna, M; Napolitano, M; Peluso, R; Tasso, M; Vastarella, M, 2021)
"Subclinical hypothyroidism affects 4."	1.56	Subclinical hypothyroidism: To treat or not to treat? ( Allen, S; Simon, C; Weidman-Evans, E, 2020)
"Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment."	1.56	Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis. ( Han, X; Ji, L; Li, M; Liu, W; Ren, Q; Wang, C; Wu, Z; Yang, W; Zhang, M; Zhang, S; Zhou, L; Zhu, Y, 2020)
"Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder in which the coexistence of autoimmune thyroiditis and thyroid gland tumours has been reported previously."	1.46	Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1? ( Güler, S; Önal, H; Yeşil, G, 2017)
"The prevalence of autoimmune thyroiditis in the general population is estimated to be at about 5-14 %."	1.42	Association between autoimmune thyroiditis and depressive disorder in psychiatric outpatients. ( Degner, D; Haust, M; Meller, J; Reulbach, U; Rüther, E, 2015)
"Thus, autoimmune thyroiditis (AIT) could be more prevalent among women with PCOS."	1.42	Polycystic ovary syndrome and chronic autoimmune thyroiditis. ( Benetti-Pinto, CL; Garmes, HM; Jales, RM; Juliato, CR; Novais, Jde S, 2015)
"The prevalence of Hashimoto thyroiditis and NHLT in the 560 papillary thyroid cancer (PTC) patients was found to be 7."	1.38	Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. ( Hong, HP; Jung, SJ; Kang, T; Kim, DW; Kim, YW; Kwon, MJ; Park, YM; Rho, MH, 2012)
"Vitiligo is the most common pigmentation-related disorder worldwide."	1.37	Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. ( Alpay, K; Bahadır, S; Okten, A; Uncu, S; Yaylı, S, 2011)
"To evaluate the prevalence of chronic autoimmune thyroiditis or Hashimoto's thyroiditis (HT) in a group of patients with spondyloarthritis (SpA)."	1.37	Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. ( Bruner, V; Del Puente, A; Di Minno, MN; Foglia, F; Iervolino, S; Lupoli, G; Lupoli, GA; Lupoli, R; Peluso, R; Scarpa, R, 2011)
"We conclude that autoimmune thyroiditis, mainly the nongoitrous form, and postoperative hypothyroidism are the foremost causes of thyroid hypofunction in male patients."	1.35	Hypothyrodism in male patients: a descriptive, observational and cross-sectional study in a series of 260 men. ( Díez, JJ; Iglesias, P, 2008)
"Chronic autoimmune thyroiditis (ATD) frequently overlaps with autoimmune rheumatic diseases."	1.35	Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. ( Benhatchi, K; Kozáková, D; Lazúrová, I; Macejova, Z; Rovenský, J; Shoenfeld, Y; Tajtáková, M; Wagnerová, H, 2009)
"Autoimmune gastritis is an additional factor affecting l-T(4) requirement in patients with autoimmune thyroiditis."	1.35	L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. ( Checchi, S; Chiappetta, MC; Ciuoli, C; De Palo, V; Montanaro, A; Pacini, F; Pasqui, L, 2008)
"i."	1.35	TRH test in patients with diabetes mellitus type 1 and/or autoimmune thyroiditis. Changes in the pituitary-thyroid axis, reverse T3, prolactin and growth hormone levels. ( Hill, M; Orlická, E; Skibová, J; Sterzl, I; Vondra, K; Zamrazil, V, 2008)
"The serum IL-18 levels in Graves' disease were significantly increased in the hyperthyroid state and were decreased during treatment with methimazole or propylthiouracil."	1.31	Increased levels of serum interleukin-18 in Graves' disease. ( Matsuura, B; Miyauchi, S; Onji, M, 2000)
"In patients with Graves' disease, APA were not associated with thyroid status."	1.31	Detection of antipituitary antibodies in patients with autoimmune thyroid disease. ( Kanda, T; Kobayashi, I; Murakami, M; Nishino, M; Yabe, S, 2001)
"For this purpose each patient with Type 1 diabetes and subclinical hypothyroidism (cases) was matched for age, duration of disease and, if possible, for sex, with two to three diabetic patients without hypothyroidism (controls)."	1.31	The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. ( Chiarelli, F; Di Luzio, R; Di Michele, S; Mohn, A; Tumini, S, 2002)
"In hyperthyroid Graves' disease, short-term methimazole is sufficient to induce lasting remission in some patients, but even long-term treatment fails to do so in others."	1.31	An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. ( Eto, S; Ito, Y; Komiya, I; Nishimori, T; Sato, A; Tanaka, Y; Terao, A; Yamada, T, 2000)
"In untreated hyperthyroid patients with Graves' disease, the CV(R-R) and HF values were significantly lower than in healthy controls."	1.30	Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism. ( Aso, Y; Fujiwara, Y; Inukai, T; Kobayashi, H; Takanashi, K; Takemura, Y; Tayama, K, 1998)
"Eighteen patients with Graves' disease, 24 patients with Hashimoto's thyroiditis and 32 sex- and age-matched healthy control subjects were studied."	1.30	Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease. ( Aguilar, M; Escobar, L; Gavilán, I; Girón, JA; Rojano, J; Sasián, S, 1998)
"We report herein a case of hyperthyroid Graves' disease developed from asymptomatic autoimmune thyroiditis (AAT)."	1.29	Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report. ( Amano, J; Fujimori, M; Hama, Y; Kasuga, Y; Kobayashi, S; Maruyama, M; Shingu, K, 1996)
"Treatment by prednisone made it possible to maintain the percentages of binding to the three tracers for two weeks at the levels reached after the fourth plasma exchange."	1.29	Reduction of anti-thyroid hormone autoantibodies through plasma exchange and corticosteroid therapy. ( Attali, JR; Perret, G; Sebaoun, J; Valensi, P, 1994)
"Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI."	1.29	Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. ( Fukui, T; Mori, M; Nagamine, T; Takehara, K, 1994)
"The serum P1CP levels of the untreated Graves' disease were significantly higher than in the controls (176."	1.29	Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease. ( Demura, H; Miyakawa, M; Tsushima, T, 1996)
"Whenever thyroid lymphoma is suspected, we recommend an ultrasound scan of the thyroid gland and fine needle aspiration biopsy as initial diagnostic procedures."	1.29	Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. ( Ikeda, H; Katayama, S; Kuma, K; Matsuzuka, F; Miyauchi, A; Narabayashi, I; Sugawara, M, 1993)
"Fourteen patients were affected by Graves' disease, eight by silent thyroiditis, five by Hashimoto's thyroiditis."	1.29	Anti-cardiolipin antibodies in autoimmune thyroid diseases. ( Afeltra, A; Amoroso, A; Bonomo, L; Caccavo, D; Di Prima, MA; Ferri, GM; Paggi, A; Vaccaro, F, 1994)
"Hypothyroidism in some patients with autoimmune thyroiditis may be due to thyrotropin-blocking antibodies."	1.28	Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. ( Aizawa, T; Asawa, T; Koizumi, Y; Komiya, I; Nagasawa, Y; Shinoda, T; Takasu, M; Takasu, N; Yamada, T, 1992)
"Thus, it is possible that Graves' disease, subacute aggravation of chronic thyroiditis and hypothyroidism coexist in the same individual."	1.28	Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism. ( Kouchi, T; Mashiba, H; Mitani, Y; Shigemasa, C; Shirota, K; Ueta, Y; Urabe, K; Yoshida, A, 1991)
"In 26 patients with untreated Graves' disease and 7 hyperthyroid patients with Hashimoto's thyroiditis, the mean levels of soluble IL-2 receptor were both significantly higher than in normal controls (1497 +/- 649 (mean +/- SD), 641 +/- 137 vs 221 +/- 63 10(3) U/l, p less than 0."	1.28	Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. ( Nakanishi, K; Ohta, Y; Taniguchi, Y, 1991)
"A month after rubella infection, she developed heat intolerance."	1.28	Silent thyroiditis following rubella. ( Kosaka, J; Nakamura, S; Shima, H; Sugimoto, M; Takuno, H; Watanabe, H, 1990)
"Thalidomide did not suppress the incidence of lymphocytic thyroiditis and serum anti-thyroglobulin antibodies or affect the serum concentrations of T4, T3 and TSH in this rat model."	1.28	Effect of thalidomide on the incidence of iodine-induced and spontaneous lymphocytic thyroiditis and spontaneous diabetes mellitus in the BB/Wor rat. ( Abend, S; Alex, S; Appel, MC; Braverman, LE; Lueprasitsakul, W; Reinhardt, W, 1990)
"These data suggest that autoimmune thyroiditis associated with a mild "subclinical" form of hypothyroidism is common in adult DS patients and more pronounced in patients with AD manifestations than in those without."	1.28	Autoimmune thyroiditis associated with mild "subclinical" hypothyroidism in adults with Down syndrome: a comparison of patients with and without manifestations of Alzheimer disease. ( Andrews, DF; Crapper McLachlan, DR; Dalton, AJ; Gera, E; Hummel, JT; Markovic, VD; Percy, ME; Rusk, AC; Somerville, MJ; Walfish, PG, 1990)
"Myxedema coma is an endocrine emergency that requires prompt treatment of both the metabolic complications and any intercurrent illness."	1.27	Adult hypothyroidism. 2. Causes, laboratory diagnosis, and treatment. ( Mazzaferri, EL, 1986)
"Two patients with persistent lymphocytic thyroiditis and thyrotoxicosis were studied."	1.27	Immunologic studies in two patients with persistent lymphocytic thyroiditis, thyrotoxicosis, and low radioactive iodine uptake. ( Elliot, I; Gupta, M; Hostetter, A; Sheeler, L; Skillern, P; Tubbs, R, 1984)
"Patients with Graves' disease were divided into the following two groups: (1) untreated, and (2) euthyroid during antithyroid drug (methylmercaptoimidazole) therapy."	1.27	[Studies on the suppressor T cell function in patients with autoimmune thyroid diseases]. ( Matsui, J, 1984)
"In methimazole-treated patients with T3-suppressible thyroid uptake, anti-DNA antibody was found in 9% (3 of 35)."	1.27	Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. ( Aizawa, T; Hiramatsu, K; Ishihara, M; Kameko, M; Kanai, M; Katakura, M; Maruyama, K; Takasu, N; Yamada, T; Yukimura, Y, 1987)
"Thyroidal Graves' disease--past or present--was clinically evident in 99 patients (79%): hyperthyroidism in 3 cases."	1.27	Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. ( Koornneef, L; Smit, T; van der Gaag, R; Wiersinga, WM, 1988)
"One patient had Graves' disease, the second patient had Hashimoto's disease which has been only infrequently associated with T3 toxicity in adults."	1.26	T3 toxicosis in children. ( Fawcett, DM; Harland, PC; McArthur, RG, 1977)
" The high circulating levels of D-T4 and possibly of D-T3 after chronic administration of D-T4 may be responsible for the saturation of pituitary nuclear T3 receptors, resulting in the suppression of the TRH-induced TSH response."	1.26	Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults. ( Brun, LD; Coulombe, P; Dussault, JH; Gagné, C; Lupien, PJ; Moorjani, S, 1980)
"Goiter was the most consistent finding in both groups and was present in all instances of spontaneously acquired primary hypothyroidism."	1.26	Clinical recognition of juvenile hypothyroidism in the early stage. ( Abbassi, V; Cancellieri, RP; Rigterink, E, 1980)
"A 51-year-old woman with chronic lymphocytic thyroiditis showed transient thyrotoxicosis at seven weeks after cessation of steroid therapy for treatment of rheumatoid arthritis."	1.26	Transient thyrotoxicosis occurred after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis. ( Kataoka, K; Kato, M; Maruyama, H; Matsuki, S; Mizuno, O, 1982)
"In untreated patients with Graves' disease, the percentage of T gamma lymphocytes (mean +/- SD, 8."	1.26	Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. ( Amino, N; Asari, S; Iwatani, Y; Izumiguchi, Y; Kumahara, Y; Miyai, K; Mori, H, 1982)
"The incidence of lymphocytic thyroiditis was strikingly increased in 8-10-mo-old diabetic rats (59%) as compared with their nondiabetic cohorts (11%) (P less than 0."	1.26	Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. ( Braverman, LE; Like, AA; Sarantis, K; Sternthal, E, 1981)
"The group of patients with thyroid adenoma served as control (group I)."	1.26	TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy. ( Fukuda, H; Kamio, N; Kobayashi, I; Kobayashi, S; Maruta, S; Ohsawa, N; Ohshima, K; Suwa, K, 1981)
"2) In 30 cases with 131I treated Graves' disease, TSH concentration was 22."	1.25	[Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treate ( Takeda, Y, 1975)

Timeframe	Studies, this research(%)	All Research%
pre-1990	130 (46.43)	18.7374
1990's	57 (20.36)	18.2507
2000's	51 (18.21)	29.6817
2010's	31 (11.07)	24.3611
2020's	11 (3.93)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Long-term Follow-up After Treatment of Chronic Autoimmune Thyroiditis With Low Level Laser[NCT02240563]		43 participants (Actual)	Interventional	2014-09-30	Completed
L-selenomethionine Supplementation in Children and Adolescents With Autoimmune Thyroiditis: a Randomized Blind Placebo-controlled Clinical Trial[NCT02644707]	Phase 4	100 participants (Actual)	Interventional	2014-08-31	Completed
Selenium Treatment in Autoimmune Thyroiditis: Long Term Follow-Up With Variable Doses[NCT00271427]		100 participants	Interventional	2004-12-31	Completed
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine[NCT06083636]		500 participants (Anticipated)	Observational	2022-07-26	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocrine journal, 2021, Feb-28, Volume: 68, Issue:2 Topics: Angiotensin-Converting Enzyme 2; COVID-19; Graves Disease; Humans; Hypothyroidism; Mortality; Progno	2021
Resistance to thyroid hormone β in autoimmune thyroid disease: a case report and review of literature. BMC pregnancy and childbirth, 2018, Dec-03, Volume: 18, Issue:1 Topics: Adult; Diabetes Mellitus, Type 2; Female; Hashimoto Disease; Humans; Hypothyroidism; Mutation; Postp	2018
Influence of cigarette smoking on thyroid gland--an update. Endokrynologia Polska, 2014, Volume: 65, Issue:1 Topics: Female; Graves Disease; Hashimoto Disease; Humans; Hyperthyroidism; Hypothyroidism; Pregnancy; Pregn	2014
Selenium and thyroid. Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:6 Topics: Clinical Trials as Topic; Humans; Hypothyroidism; Immunity; Iodide Peroxidase; Selenium; Selenoprote	2009
MYXOEDEMA COMA. TWO CASE REPORTS AND A REVIEW. Acta endocrinologica, 1964, Volume: 45 Topics: Autoimmune Diseases; Coma; Geriatrics; Humans; Hydrocortisone; Hyponatremia; Hypothermia; Hypothermi	1964
THYROIDITIS IN CHILDHOOD. Advances in pediatrics, 1964, Volume: 13 Topics: Adenoma; Alpha-Globulins; Antibody Formation; Antigens; Autoantibodies; Autoimmune Diseases; Beta-Gl	1964
Peripheral thyroid dysfunction in depression. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2006, Volume: 7, Issue:3 Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypothalamo-Hy	2006
Neuropsychiatric aspects of hypothyroidism and treatment reversibility. . Minerva endocrinologica, 2007, Volume: 32, Issue:1 Topics: Adult; Age Factors; Aged; Animals; Autoantibodies; Brain; Cerebrovascular Circulation; Cognition Dis	2007
The role of thyroid autoimmunity in fertility and pregnancy. Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:7 Topics: Abortion, Spontaneous; Adult; Female; Humans; Infertility, Female; Pregnancy; Thyroid Diseases; Thyr	2008
Radioimmunoassay of human thyrotropin: analytical and clinical developments. Critical reviews in clinical laboratory sciences, 1984, Volume: 20, Issue:3 Topics: Adolescent; Adult; Aged; Aging; Child; Child, Preschool; Circadian Rhythm; Female; Goiter; Graves Di	1984
Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocrine reviews, 1980,Fall, Volume: 1, Issue:4 Topics: Adolescent; Adult; Aged; Autoantibodies; Child; Child, Preschool; Female; Humans; Hyperthyroidism; I	1980
[Primary hypothyroidism]. Ryoikibetsu shokogun shirizu, 2000, Issue:31 Topics: Autoimmune Diseases; Congenital Hypothyroidism; Diagnosis, Differential; Humans; Hypothyroidism; Pro	2000
Endocrine exophthalmos: an immunologic aberration. Ophthalmic seminars, 1977, Volume: 2, Issue:2 Topics: Autoantibodies; Exophthalmos; Graves Disease; Humans; Immunity; Immunity, Cellular; Immunoglobulin G	1977
Investigation of thyroid diseases. Recent advances in clinical nuclear medicine, 1975, Volume: 1 Topics: Goiter, Endemic; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Radioimmunoassay; Te	1975
The diagnostic use of radionuclides in the thyroid disorders of childhood. Seminars in nuclear medicine, 1971, Volume: 1, Issue:3 Topics: Blood Proteins; Child; Diagnosis, Differential; Female; Fetus; Humans; Hypothyroidism; Infant, Newbo	1971

Article	Year
[The effect of selenium therapy on autoimmune thyroiditis]. Orvosi hetilap, 2008, Jun-29, Volume: 149, Issue:26 Topics: Adult; Antioxidants; Autoantibodies; Double-Blind Method; Female; Follow-Up Studies; Humans; Iodide	2008
Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers in surgery and medicine, 2010, Volume: 42, Issue:6 Topics: Adult; Autoantibodies; Chronic Disease; Female; Humans; Hypothyroidism; Iodide Peroxidase; Low-Level	2010
Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. European journal of endocrinology, 2003, Volume: 148, Issue:4 Topics: Adult; Autoantibodies; Female; Humans; Iodide Peroxidase; Kinetics; Male; Middle Aged; Placebos; Pro	2003
Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto's thyroiditis. Endocrine journal, 2005, Volume: 52, Issue:3 Topics: Adult; Autoantibodies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometr	2005
Thyroid hormone increases mannan-binding lectin levels. European journal of endocrinology, 2005, Volume: 153, Issue:5 Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Ma	2005
Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. The Journal of endocrinology, 2006, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Antibodies, Monoclonal; Drug Administration Schedule; Female; Follow-Up	2006
Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. The Journal of endocrinology, 2006, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Antibodies, Monoclonal; Drug Administration Schedule; Female; Follow-Up	2006
Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. The Journal of endocrinology, 2006, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Antibodies, Monoclonal; Drug Administration Schedule; Female; Follow-Up	2006
Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. The Journal of endocrinology, 2006, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Antibodies, Monoclonal; Drug Administration Schedule; Female; Follow-Up	2006
Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology, 2000, Aug-22, Volume: 55, Issue:4 Topics: Adult; Autoantibodies; Drug Administration Schedule; Female; Humans; Interferon beta-1a; Interferon	2000

triiodothyronine and Autoimmune Thyroiditis

Research Excerpts

Research

Studies (280)

Authors

Clinical Trials (4)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Cristinel Badiu, D	1
Popescu, GC	1
Zgura, A	1
Mercan Stanciu, A	1
Dodot, MD	1
Mehedintu, C	1
Toma, L	1
Razvan, S	1
Bacinschi, X	1
Haineala, B	1
Fierabracci, P	1
Basolo, A	1
Scartabelli, G	1
Bechi Genzano, S	1
Salvetti, G	1
Sotgia, G	1
Rotondi, M	4
Chiovato, L	3
Ceccarini, G	1
Santini, F	1
Zhang, C	2
Zhang, Q	1
Qin, L	2
Yan, Z	1
Wu, L	2
Liu, T	2
Kir, S	1
Gorar, S	1
Sari, IK	1
Ellidag, HY	1
Cekin, AH	1
Yilmaz, E	1
Hoermann, R	1
Pekker, MJ	1
Midgley, JEM	1
Larisch, R	1
Dietrich, JW	1
Simon, C	1
Weidman-Evans, E	1
Allen, S	1
Pace, C	1
Tumino, D	1
Russo, M	1
Le Moli, R	1
Naselli, A	1
Borzì, G	1
Malandrino, P	1
Frasca, F	1
Vastarella, M	1
Megna, M	1
Lupoli, GA	2
Napolitano, M	1
Gallo, L	1
Balato, A	1
Tasso, M	1
Costa, L	1
Fabbrocini, G	1
Peluso, R	2
Speer, G	1
Somogyi, P	1
Wu, Z	1
Zhu, Y	1
Zhang, M	1
Wang, C	1
Zhou, L	1
Liu, W	1
Yang, W	1
Li, M	1
Zhang, S	1
Ren, Q	1
Han, X	1
Ji, L	1
Sun, B	1
Wu, Y	1
Zhong, F	1
Güler, S	1
Yeşil, G	1
Önal, H	1
Al-Rabia, MW	1
Canepa, C	1
Srinivasan, R	1
Muhith, A	1
Guo, Q	1
Wu, D	2
Yu, H	1
Bao, J	1
Peng, S	1
Shan, Z	3
Guan, H	2
Teng, W	2
Jondhale, SN	1
Save, SU	1
Koppikar, RG	1
Bavdekar, SB	1
Ahmad, S	1
Giannopoulou, A	1
Owen, P	1
Kalhan, A	1
Guo, R	1
Guo, H	1
Li, Y	2
Hansen, PR	1
Isaksen, JL	1
Jemec, GB	1
Ellervik, C	1
Kanters, JK	1
Lin, JD	1
Fang, WF	1
Tang, KT	1
Cheng, CW	1
Sawicka-Gutaj, N	1
Gutaj, P	1
Sowiński, J	1
Wender-Ożegowska, E	1
Czarnywojtek, A	1
Brązert, J	1
Ruchała, M	1
Degner, D	1
Haust, M	1
Meller, J	1
Rüther, E	1
Reulbach, U	1
Novais, Jde S	1
Benetti-Pinto, CL	1
Garmes, HM	1
Jales, RM	1
Juliato, CR	1
Karakose, M	1
Karbek, B	1
Sahin, M	1
Arslan, MS	1
Topaloglu, O	1
Erden, G	1
Demirci, T	1
Calıskan, M	1
Delibasi, T	1
Bliddal, S	1
Boas, M	1
Hilsted, L	1
Friis-Hansen, L	1
Tabor, A	1
Feldt-Rasmussen, U	3
Muscogiuri, G	2
Palomba, S	1
Caggiano, M	1
Tafuri, D	1
Colao, A	1
Orio, F	1
Argatska, A	1
Nonchev, B	1
Orbetzova, M	1
Pehlivanov, B	1
Stoian, D	1
Pantea, S	1
Margan, M	1
Timar, B	1
Borcan, F	1
Craina, M	1
Craciunescu, M	1
Şıklar, Z	1
Karataş, D	1
Doğu, F	1
Hacıhamdioğlu, B	1
İkincioğulları, A	1
Berberoğlu, M	1
Teti, C	1
Nazzari, E	1
Galletti, MR	1
Mandolfino, MG	1
Pupo, F	1
Pesce, G	1
Lillo, F	1
Bagnasco, M	1
Benvenga, S	3
Mari, D	1
Prolo, S	1
Fatti, LM	1
Cantone, MC	1
Garagnani, P	1
Arosio, B	1
Di Somma, C	1
Vitale, G	1
Balázs, C	2
Mouzouri, H	1
El Omri, N	1
Sekkach, Y	1
Frikh, R	1
Nzambe, C	1
Qacif, H	1
Baizri, H	1
Makouar, F	1
Qatni, ME	1
Belmejdoub, G	1
Rkiouak, F	1
Ghafir, D	1
Ohayon, V	1
Archane, MI	1
Alexandrescu, DT	1
Popoveniuc, G	1
Farzanmehr, H	1
Dasanu, CA	1
Dawson, N	1
Wartofsky, L	1
Radetti, G	1
Kleon, W	1
Buzi, F	1
Crivellaro, C	1
Pappalardo, L	1
di Iorgi, N	1
Maghnie, M	1
Iglesias, P	1
Díez, JJ	1
Giovanella, L	1
Dorizzi, RM	1
Keller, F	1
Leporati, P	1
La Manna, A	1
Pirali, B	1
Mondello, T	1
Fonte, R	1
Magri, F	1
Morel, S	1
Georges, A	1
Bordenave, L	1
Corcuff, JB	1
Tanda, ML	1
Lombardi, V	1
Genovesi, M	1
Ultimieri, F	1
Lai, A	1
Gandolfo, M	1
Dalle Mule, I	1
Grasso, L	1
Bogazzi, F	1
Broglio, F	1
Ghigo, E	1
Martino, E	1
Bartalena, L	1
Lazúrová, I	1
Benhatchi, K	1
Rovenský, J	1
Kozáková, D	1
Wagnerová, H	1
Tajtáková, M	1
Shoenfeld, Y	1
Macejova, Z	1
Köhrle, J	1
Gärtner, R	1
Nataloni, IF	1
Ceriani, E	1
Foieni, F	1
Montano, N	1
Cicardi, M	1
Höfling, DB	1
Chavantes, MC	1
Juliano, AG	1
Cerri, GG	1
Romão, R	1
Yoshimura, EM	1
Chammas, MC	1
Kordonouri, O	1
Charpentier, N	1
Hartmann, R	1
Uncu, S	1
Yaylı, S	1
Bahadır, S	1
Okten, A	1
Alpay, K	1
Teng, X	1
Chen, Y	1
Lai, Y	1
Yu, J	1
Shan, L	1
Bai, X	1
Li, N	1
Li, Z	1
Wang, S	1
Xing, Q	1
Xue, H	1
Zhu, L	1
Hou, X	1
Fan, C	1
Del Puente, A	1
Iervolino, S	1
Bruner, V	1
Lupoli, R	1
Di Minno, MN	1
Foglia, F	1
Scarpa, R	1
Lupoli, G	1
Krupińska, J	1
Wawrzynowicz-Syczewska, M	1
Urbanowicz, W	1
Pobłocki, J	1
Syrenicz, A	1
Rho, MH	1
Kim, DW	1
Hong, HP	1
Park, YM	1
Kwon, MJ	1
Jung, SJ	1
Kim, YW	1
Kang, T	1
Zaccarelli-Marino, MA	1
Türke, B	1
Vámos, A	1
Sviridonova, MA	1
Fadeyev, VV	1
Sych, YP	1
Melnichenko, GA	1
Tanikawa, T	1
Okada, Y	1
Zeki, K	1
Kanda, K	1
Morita, E	1
Tanaka, Y	2
Duntas, LH	1
Mantzou, E	1
Koutras, DA	1
BANSI, HW	1
NIELSEN, PE	1
RANLOV, P	1
LEBOEUF, G	1
BONGIOVANNI, AM	1
SKILLERN, PG	1
BRAVERMAN, LE	7
INGBAR, SH	2
TORIZUKA, K	3
FLAX, MH	1
STANBURY, JB	2
HIGGINS, HP	1
ELKAN, I	1
DIOSY, A	1
BAYLEY, TA	1
BUCKLEY, GC	1
SAXENA, KM	1
Amino, N	6
Hidaka, Y	2
Takano, T	1
Tatsumi, KI	1
Izumi, Y	1
Nakata, Y	1
Trimarchi, F	2
Atabek, ME	1
Pirgon, O	1
Erkul, I	1
Hartoft-Nielsen, ML	1
Rasmussen, AK	1
Kaas, A	1
Buschard, K	1
Mazziotti, G	1
Sorvillo, F	1
Piscopo, M	1
Cioffi, M	1
Amato, G	1
Carella, C	1
Palma-Carlos, AG	1
Palma-Carlos, ML	1
Aksoy, DY	1
Kerimoglu, U	1
Okur, H	1
Canpinar, H	1
Karaağaoğlu, E	1
Yetgin, S	1
Kansu, E	1
Gedik, O	1
Azizi, F	2
Livadas, S	1
Xekouki, P	1
Fouka, F	1
Kanaka-Gantenbein, C	1
Kaloumenou, I	1
Mavrou, A	1
Constantinidou, N	1
Dacou-Voutetakis, C	1
Riis, AL	1
Hansen, TK	1
Thiel, S	1
Gravholt, CH	1
Gjedde, S	1
Gormsen, LC	1
Jørgensen, JO	1
Weeke, J	1
Møller, N	1
Antonelli, A	1
Fallahi, P	1
Romagnani, P	1
Ferrari, SM	1
Barani, L	1
Ferrannini, E	2
Serio, M	1
Poppe, K	3
Glinoer, D	2
Tournaye, H	1
Maniewski, U	1
Haentjens, P	1
Velkeniers, B	3
Svensson, J	2
Ericsson, UB	3
Nilsson, P	2
Olsson, C	1
Jonsson, B	1
Lindberg, B	2
Ivarsson, SA	2
Conte, M	1
Arcaro, A	1
D'Angelo, D	1
Gnata, A	1
Mamone, G	1
Ferranti, P	1
Formisano, S	1
Gentile, F	1
Turker, O	1
Kumanlioglu, K	1
Karapolat, I	1
Dogan, I	1
Fountoulakis, KN	1
Kantartzis, S	1
Siamouli, M	1
Panagiotidis, P	1
Kaprinis, S	1
Iacovides, A	1
Kaprinis, G	1
Kvetny, J	1
Poulsen, H	1
Davis, JD	1
Tremont, G	1
Medeiros, CC	1
Lemos-Marini, SH	1
Brícola Filho, M	1
Camargo, EE	1
Santos, AO	1
Magna, LA	1
Guerra Júnior, G	1
Baptista, MT	1
Maciel-Guerra, AT	1
Checchi, S	1
Montanaro, A	1
Pasqui, L	1
Ciuoli, C	1
De Palo, V	1
Chiappetta, MC	1
Pacini, F	1
Orlická, E	1
Vondra, K	1
Hill, M	1
Skibová, J	1
Sterzl, I	1
Zamrazil, V	1
Drbalová, K	1
Matucha, P	1
Matějková-Běhanová, M	1
Bílek, R	1
Kříž, L	1
Kazihnitková, H	1
Hampl, R	1
Grassetto, G	1
Rubello, D	1
Matsui, J	1
Waldstein, SS	1
Mori, H	2
Iwatani, Y	2
Asari, S	2
Izumiguchi, Y	2
Kumahara, Y	1
Miyai, K	3
Sugawara, M	2
Lau, R	1
Wasser, HL	1
Nelson, AM	1
Kuma, K	3
Hershman, JM	2
Elliot, I	1
Gupta, M	1
Hostetter, A	1
Sheeler, L	1
Skillern, P	1
Tubbs, R	1
Wehmann, RE	1
Nisula, BC	1
Sasaki, N	1
Tsuyusaki, T	1
Sanayama, K	1
Inomata, H	1
Niimi, H	1
Nakajima, H	1
Zefirova, GS	1
Ibragimova, GV	1
Kondrat'eva, LV	1
Shchepetkova, LV	1
Davitinidze, NL	1
Cabrer, J	1
Angel, M	1
Faus, R	1
Vilardell, E	1
Sasaki, H	1
Eimoto, T	1
Yamamoto, T	1
Asano, T	1
Okamura, M	1
Yamamoto, M	6
Kaise, K	5
Kitaoka, H	1
Yoshida, K	5
Kaise, N	6
Fukazawa, H	1
Sakurada, T	5
Saito, S	5
Yoshinaga, K	3
Costante, G	1
Barbera, C	1
Melluso, R	1
Marcocci, C	1
De Luca, F	1
Consolo, F	1
Nakamura, S	7
Kojima, N	3
Kamikubo, K	4
Sakata, S	9
Yasuda, K	3
Miura, K	8
Alekseeva, RM	1
Bazarova, EN	1
Bobrovskaia, TA	1
Murayama, M	1
Brun, LD	1
Gagné, C	1
Coulombe, P	1
Lupien, PJ	1
Dussault, JH	1
Moorjani, S	1
Ohsawa, N	1
Kobayashi, I	2
Suwa, K	1
Kamio, N	1
Maruta, S	1
Ohshima, K	1
Fukuda, H	1
Kobayashi, S	3
Gold, MS	1
Pottash, AL	1
Extein, I	1
Abbassi, V	2
Rigterink, E	1
Cancellieri, RP	1
Faerch, T	2
Højslet, PE	2
Mose, C	1
Påby, P	2
Sternthal, E	1
Like, AA	1
Sarantis, K	1
Fushimi, K	2
Okuyama, M	2
Taylor, HC	1
Sheeler, LR	1
Nikolai, TF	1
Coombs, GJ	1
McKenzie, AK	1
Miller, RW	1
Weir, GJ	1
Suzuki, Y	1
Takeshita, E	1
Kano, S	1
Hirata, S	1
Sato, S	2
Maruyama, H	1
Kato, M	1
Mizuno, O	1
Kataoka, K	1
Matsuki, S	1
Woolf, PD	1
Erfurth, EM	1
Schütz, A	1
Sugenoya, A	1
Itoh, N	1
Kasuga, Y	2
Ohhashi, T	1
Nagai, N	1
Iida, F	1
Valensi, P	1
Perret, G	1
Attali, JR	1
Sebaoun, J	1
Kochańska-Dziurowicz, A	1
Starzewski, JJ	1
Dunal, W	1
Yoshikawa, N	1
Morita, T	2
Arreaza, G	1
Resetkova, E	1
Mukuta, T	2
Volpé, R	1
Nishi, I	1
Tamaki, H	1
Takeoka, K	1
Tada, H	2
Mitsuda, N	1
Nagamine, T	1
Takehara, K	1
Fukui, T	1
Mori, M	1
Parkes, AB	2
Black, EG	1
Adams, H	1
John, R	1
Richards, CJ	1
Hall, R	2
Lazarus, JH	2
Paggi, A	1
Caccavo, D	1
Ferri, GM	1
Di Prima, MA	1
Amoroso, A	1
Vaccaro, F	1
Bonomo, L	1
Afeltra, A	1
Giammarco, V	1
Mariani, S	1
Romeo, MV	1
Matsuzuka, F	1
Miyauchi, A	1
Katayama, S	1
Narabayashi, I	1
Ikeda, H	1
Mooij, P	1
de Wit, HJ	1
Drexhage, HA	2
Hu, G	1
Chen, H	1
Hou, Y	1
He, J	1
Cheng, Z	1
Wang, R	1
Schulze-Bonhage, A	1
Fiedler, M	1
Ferbert, A	1
Miyakawa, M	1
Tsushima, T	1
Demura, H	1
Fujimori, M	1
Shingu, K	1
Hama, Y	1
Maruyama, M	1
Amano, J	1
Notsu, K	1
Ito, Y	2
Furuya, H	1
Ohguni, S	1
Kato, Y	1
Plengvidhya, N	1
Sunthornthepvarakul, T	1
Vannasaeng, S	1
Kabadi, UM	1
Doldi, N	1
Taccagni, GL	1
Bassan, M	1
Frigerio, L	1
Mangili, G	1
Jansen, AM	1
Ferrari, A	1
Itoh, M	1
Uchimura, K	1
Hayakawa, N	1
Makino, M	2
Hayashi, R	1
Nagata, M	1
Kakizawa, H	1
Nagasaka, A	1
Sakamoto, H	1
Kuzuya, H	1
Sasián, S	1
Rojano, J	1
Gavilán, I	1
Aguilar, M	1
Escobar, L	1
Girón, JA	1
Inukai, T	1
Takanashi, K	1
Kobayashi, H	1
Fujiwara, Y	1
Tayama, K	1
Aso, Y	1
Takemura, Y	1
Marwaha, RK	1
Sankar, R	1
Magdum, M	1
Nijahvan, VS	1
Khanna, CM	1
Jaggi, CB	1
Ambardar, V	1
Maharda, NS	1
Walia, RP	1
Jain, SK	1
Frati, R	1
Frati, C	1
Sassano, PP	1
Antonaci, A	1
Lange, U	1
Boss, B	1
Teichmann, J	1
Klett, R	1
Stracke, H	1
Bretzel, RG	1
Neeck, G	1
Verbruggen, LA	1
Finné, E	2
Body, JJ	1
Vanhaelst, L	2
Franzese, A	1
Buono, P	1
Mascolo, M	1
Leo, AL	1
Valerio, G	1
Yamada, T	6
Sato, A	1
Komiya, I	3
Nishimori, T	1
Terao, A	1
Eto, S	1
Monzani, F	1
Caraccio, N	1
Casolaro, A	1
Lombardo, F	1
Moscato, G	1
Murri, L	1
Meucci, G	1
Chantelau, E	1
Miyauchi, S	1
Matsuura, B	1
Onji, M	1
Pereira, FO	1
Graf, H	1
Nomura, LM	1
Neto, JZ	1
Collaço, LM	1
Boguszewski, CL	1
Simons, PJ	1
Delemarre, FG	1
Chinyanga, EA	1
Benni, A	1
Siziya, S	1
Svenonius, E	1
Nishino, M	1
Yabe, S	1
Murakami, M	1
Kanda, T	1
Mohn, A	1
Di Michele, S	1
Di Luzio, R	1
Tumini, S	1
Chiarelli, F	1
Woeber, KA	1
Hara, H	1
Sato, R	1
Ban, Y	1
Endo, K	2
Kasagi, K	2
Konishi, J	3
Ikekubo, K	4
Okuno, T	2
Takeda, Y	4
Mori, T	3
Nakajima, K	1
Nagata, I	1
Bigos, ST	1
Ridgway, EC	1
Kourides, IA	1
Maloof, F	2
Ikejiri, K	1
Kotani, M	1
Kusakabe, T	2
Aizawa, T	3
Koizumi, Y	2
Tawata, M	1
Nagata, H	1
Izumiyama, T	1
Yoshizawa, K	1
Kaplan, HJ	1
Spaulding, SW	1
Chopra, IJ	2
Solomon, DH	2
Chopra, U	1
Yoshihara, E	1
Terasaki, PI	1
Smith, F	1
Aldige, C	1
Verdy, M	1
Bélanger, R	2
Bellabarba, D	2
Pretty, H	1
Labrecque, R	1
Denko, JD	1
Harland, PC	1
McArthur, RG	1
Fawcett, DM	1
Abe, R	1
Kimura, M	1
Kumar, MS	1
Safa, AM	1
Deodhar, SD	1
Schumacher, OP	1
Ginsberg, J	1
Segal, D	1
Ehrlich, RM	1
Walfish, PG	2
Nakashima, T	2
Shiroozu, A	1
Okamura, K	1
Inoue, K	2
Omae, T	2
Hisatsugu, T	1
Yoshizumi, T	1
Geiser, J	1
Bürgi, H	1
Grob, PJ	1
Studer, H	1
Mallya, RK	1
Isaacs, AJ	1
Bayliss, R	1
Wu, SY	1
Bennett, LR	1
Vagenakis, AG	1
Portnay, GI	1
Rapoport, B	1
Stahl, TJ	1
Beckers, C	1
Hood, S	1
Vaughan-Jackson, JD	1
Farid, NR	1
Herrmann, J	1
Kley, HK	1
Rudorff, KH	1
Kröll, HJ	1
Krüskemper, HL	1
Saberi, M	1
Sterling, FH	1
Utiger, RD	1
Volpert, EM	1
Prezyna, AP	1
Gaeta, JF	1
Koepf, GF	1
Bevan, JS	1
Othman, S	1
Scrimshaw, BJ	1
Fellowes, AP	1
Palmer, BN	1
Croxson, MS	1
Stockigt, JR	1
George, PM	1
Thacker, EL	1
Refsal, KR	1
Bull, RW	1
Maekawa, H	2
Ogawa, T	2
Sarui, H	1
Matsuda, M	2
Endo, J	1
Wada, S	1
Nagai, K	3
Lueprasitsakul, W	2
Alex, S	2
Fang, SL	2
Appel, MC	3
Berglund, J	1
Bondeson, L	1
Christensen, SB	1
Tibblin, S	1
Nakanishi, K	1
Taniguchi, Y	1
Ohta, Y	1
Shigemasa, C	1
Shirota, K	1
Urabe, K	1
Kouchi, T	1
Mitani, Y	1
Ueta, Y	1
Yoshida, A	1
Mashiba, H	1
Schifferdecker, E	1
Tachi, J	1
Marsh, JA	1
Johnson, BE	1
Lillehoj, HS	1
Scanes, CG	1
Takasu, N	3
Takasu, M	1
Nagasawa, Y	2
Asawa, T	2
Shinoda, T	1
Tokmakjian, SD	1
Haines, DS	1
Edmonds, MW	1
Picco, P	1
Mazzella, M	1
Cotellessa, M	1
Pistoia, V	1
Tamai, H	1
Oshima, A	1
Fukata, S	1
Kumagai, LF	1
Nagataki, S	2
Noh, J	1
Hamada, N	1
Saito, H	1
Yoshimoto, M	1
Iwasaki, H	1
Ozaki, O	1
Okamoto, Y	1
Ito, K	1
Morii, H	1
Takuno, H	3
Kimata, Y	1
Takeda, N	1
Ochi, Y	2
Miura, Y	1
Tokuta, H	1
Yamamori, I	1
Imamura, S	1
Takagi, N	1
Mori, Y	1
Oiso, Y	1
Percy, ME	1
Dalton, AJ	1
Markovic, VD	1
Crapper McLachlan, DR	1
Gera, E	1
Hummel, JT	1
Rusk, AC	1
Somerville, MJ	1
Andrews, DF	1
Djurica, S	1
Zakula, Z	1
Isenović, E	1
Ratković, M	1
Ribarac-Stepić, N	1
Rasmussen, NG	1
Hornnes, PJ	1
Høier-Madsen, M	1
Hegedüs, L	1
Chen, HP	2
He, JS	2
Hu, GS	2
Rom-Bugoslavskaia, ES	1
Sakhatov, BIa	1
Pesotskaia, PM	1
Kosaka, J	1
Sugimoto, M	1
Watanabe, H	1
Shima, H	1
Abend, S	1
Reinhardt, W	1
Varl, B	1
Pavlin, K	1
Bagchi, N	2
Brown, TR	2
Herdegen, DM	2
Dhar, A	1
Sundick, RS	3
Stefăneanu, L	1
Taşcă, C	1
Chen, G	1
Zhang, KZ	1
Liao, ZH	1
Wang, SH	1
Ma, SJ	1
Long, ZZ	1
Tian, WT	1
Zhu, JY	1
Komaki, T	2
Rajatanavin, R	1
Pino, S	1
Laurberg, P	1
Smith, M	1
Bullock, LP	1
Foley, TP	1
White, C	1
New, A	1
Wiersinga, WM	1
Smit, T	1
van der Gaag, R	1
Koornneef, L	1
Chastain, CB	1
Young, DW	1
Kemppainen, RJ	1
Fischer, PW	1
Campbell, JS	1
Giroux, A	1
Mazzaferri, EL	1
Deboel, S	1
Bonnyns, M	1
Jonckheer, M	1
Buydens, P	1
Smitz, J	1
Ferrari, C	1
Paracchi, A	1
Parisio, E	1
Codecasa, F	1
Mucci, M	1
Boghen, M	1
Gerevini, G	1
Rampini, P	1
Bános, C	3
Takó, J	3
Földes, J	3
Kelecsényi, E	1
Trembeczki, S	1
Muratsugu, M	1
Tsuchiya, Y	1
Schröder, F	1
Burandt, S	1
Friedrich, K	1
Tomita, M	1
Ushida, S	1
Nakahara, Y	2
Ishida, T	1
Matsuyama, E	1
Tamura, T	1
Yamadori, K	1
Baba, Y	1
Togashi, K	2
Tanabashi, S	1
Kametani, M	1
Tokimitsu, N	1
Heng, JS	1
Guo, XL	1
Cheng, M	1
Sheng, JQ	1
Hong, W	1
Ye, XL	1
Hou, YJ	1
Katakura, M	1
Hiramatsu, K	1
Yukimura, Y	1
Ishihara, M	1
Maruyama, K	1
Kameko, M	1
Kanai, M	1
Dahlberg, PA	1
Petrick, PA	1
Nissim, M	1
Menezes-Ferreira, MM	1
Weintraub, BD	1
Marinoni, U	1
Marinoni, P	1
Pryds, O	1
Hadberg, A	1
Kastrup, KW	1
Fallis, G	1
Allen, EM	1
Sklar, CA	1
Qazi, R	1
David, R	1
Nagaoka, K	1
Ueno, Y	1
Chinen, Y	1
Takegami, T	1
Nakayama, A	1
Ishii, K	1
Imura, H	1
Kuno, S	1
Conaway, DH	1
Padgett, GA	1
Bunton, TE	1
Nachreiner, R	1
Hauptman, J	1
Shiomi, K	2
Hayek, A	2
Jeske, W	1
Górowski, T	1
Wong, ET	1
Doe, RP	1
Hachiya, T	1
Yoshimura, M	1
Miyazaki, T	1
Fisher, DA	1
Crawford, JD	1
Wilson, WW	1
Zellmann, HE	1
Leprat, J	1
Valcke, JC	1
Greenberg, AH	1
Czernichow, P	1
Hung, W	1
Shelley, W	1
Winship, T	1
Blizzard, RM	1
Franco, PS	1
Haigler, ED	1
Pittman, JA	1
Bergeron, D	1
Bédard, S	1
Tanaka, K	1
Mashimo, K	1
Kishino, F	1
Nishiooeda, Y	1
Tarui, S	1
Morita, R	1
Hamada, T	1
Wick, G	1
Gharib, H	1
Wahner, HW	1
McConahey, WM	2
Gyertyánfy, G	1
Gesztesi, E	2
Shenkman, L	1
Mitsuma, T	1
Hollander, CS	1
Rolland, M	1
Montfort, MF	1
Valenta, L	1
Lissitzky, S	1
Juhász, J	1
Cotton, GE	1
Gorman, CA	1
Mayberry, WE	1
McConnon, J	1
Row, VV	1
Thieme, E	1
Wyse, EP	1
Woolner, LB	1
Scholz, DA	1
Kearns, TP	1
Jones, JE	1
Shultz, JS	1